Works matching IS 00099104 AND DT 2020 AND VI 200 AND IP 2
Results: 11
Immune checkpoint inhibition: from molecules to clinical application.
- Published in:
- Clinical & Experimental Immunology, 2020, v. 200, n. 2, p. 105, doi. 10.1111/cei.13434
- By:
- Publication type:
- Article
Role of inflammasome activation in tumor immunity triggered by immune checkpoint blockers.
- Published in:
- Clinical & Experimental Immunology, 2020, v. 200, n. 2, p. 155, doi. 10.1111/cei.13433
- By:
- Publication type:
- Article
Immune checkpoint inhibitor diabetes mellitus: a novel form of autoimmune diabetes.
- Published in:
- Clinical & Experimental Immunology, 2020, v. 200, n. 2, p. 131, doi. 10.1111/cei.13424
- By:
- Publication type:
- Article
MAIT cell activation in adolescents is impacted by bile acid concentrations and body weight.
- Published in:
- Clinical & Experimental Immunology, 2020, v. 200, n. 2, p. 199, doi. 10.1111/cei.13423
- By:
- Publication type:
- Article
Mechanisms of checkpoint inhibition‐induced adverse events.
- Published in:
- Clinical & Experimental Immunology, 2020, v. 200, n. 2, p. 141, doi. 10.1111/cei.13421
- By:
- Publication type:
- Article
Comparison of elapegademase and pegademase in ADA‐deficient patients and mice.
- Published in:
- Clinical & Experimental Immunology, 2020, v. 200, n. 2, p. 176, doi. 10.1111/cei.13420
- By:
- Publication type:
- Article
High activation and skewed T cell differentiation are associated with low IL‐17A levels in a hu‐PBL‐NSG‐SGM3 mouse model of HIV infection.
- Published in:
- Clinical & Experimental Immunology, 2020, v. 200, n. 2, p. 185, doi. 10.1111/cei.13416
- By:
- Publication type:
- Article
VISTA: Coming of age as a multi‐lineage immune checkpoint.
- Published in:
- Clinical & Experimental Immunology, 2020, v. 200, n. 2, p. 120, doi. 10.1111/cei.13415
- By:
- Publication type:
- Article
Phenotypic shift of small intestinal intra‐epithelial type 1 innate lymphoid cells in celiac disease is associated with enhanced cytotoxic potential.
- Published in:
- Clinical & Experimental Immunology, 2020, v. 200, n. 2, p. 163, doi. 10.1111/cei.13414
- By:
- Publication type:
- Article
TIGIT as an emerging immune checkpoint.
- Published in:
- Clinical & Experimental Immunology, 2020, v. 200, n. 2, p. 108, doi. 10.1111/cei.13407
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical & Experimental Immunology, 2020, v. 200, n. 2, p. 1, doi. 10.1111/cei.13321
- Publication type:
- Article